Bio-Techne declares $0.08 quarterly dividend, pending Merck acquisition closure by Nov 13, 2026.

Bio-Techne Corporation announced a quarterly dividend of $0.08 per share for the period ending September 30, 2026, payable on November 23, 2026. This dividend will be paid only if the company's acquisition by Merck KGaA has not closed by November 13, 2026. The Board will continue to review future dividends quarterly. Bio-Techne is a global life sciences company with over $1.2 billion in fiscal 2026 sales and about 3,000 employees worldwide.

As of November 4, 2026, at 08:41 WIB, Bio-Techne (TECH) trades near its 52-week high at USD 72.56, just shy of the peak at USD 72.71, with a slight 1-day decline of 0.15% on Pluang. Despite the recent dividend announcement, the stock shows a modest dividend yield of 0.44% and experiences full sell-side order activity, reflecting cautious investor sentiment. The stock's market cap stands at $11.41 billion, highlighting its significant presence in the health sector.